Compare National Beverage Corp. (FIZZ) vs IDEXX Laboratories, Inc. (IDXX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
National Beverage Corp. vs IDEXX Laboratories, Inc. — how do they compare? National Beverage Corp. trades at $30.52 (market cap $2.89B), while IDEXX Laboratories, Inc. trades at $518 (market cap $40.43B). The key difference: IDEXX Laboratories, Inc. is far larger — about 14× National Beverage Corp.'s market cap, and National Beverage Corp. is trading nearer its 52-week high, IDEXX Laboratories, Inc. nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold National Beverage Corp. for 33 Days and IDEXX Laboratories, Inc. for 46 Days on average.
| FIZZ | IDXX | |
|---|---|---|
Market Cap | $2.89B | $40.43B |
Volume | 553,950 | 692,164 |
Sector | Consumer Staples | Health |
52-Week High | $37.73 | $766.68 |
52-Week Low | $29.20 | $504.70 |
Typical Hold Time | 33 Days | 46 Days |
Enterprise Value | $2.84B | $41.32B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
National Beverage Corp. (FIZZ) trades at $30.84, up 4.19% today, showing bullish technical signals despite recent earnings misses. The company maintains solid fundamentals with $1.2B revenue, 14.81% net margin, and strong ROE of 40.13%, though growth has stalled with flat revenue trends. Recent news highlights margin pressure from input costs and a special $3.25 dividend payment in July 2026.
Outlook remains cautious with 50% analyst sell ratings reflecting growth concerns, while technical strength near support at $30 offers short-term stability. Key risks include persistent margin compression and competitive pressures in the beverage sector, though valuation at 16.58 P/E appears reasonable for current earnings power.
IDEXX Laboratories (IDXX) trades at $513.14, up 1.28% with strong fundamentals including 25.03% net income margin and 74.21% ROE. The stock shows bearish technical signals but maintains consistent earnings beats and analyst consensus of $665 price target. Recent acquisition of CoVetAI expands AI capabilities in veterinary workflow intelligence, supporting long-term growth framework.
Outlook remains positive with revenue growth accelerating to $4.3B in 2025 and projected $4.6B in 2026. Key risks include foreign exchange headwinds and weaker U.S. veterinary visits. The 56.5% buy rating from analysts suggests continued confidence in the company's diagnostic innovation pipeline and recurring revenue economics.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About National Beverage Corp.
National Beverage Corp is one of the top 10 non-alcoholic beverage companies in the U.S. Its portfolio skews toward functional drinks (that is those purporting to offer health benefits) and is anchored by the popular LaCroix sparkling water trademark. Other offerings include Rip It energy drinks, Everfresh juices, and soda brands like Shasta and Faygo. The firm controls most of its production and distribution apparatus, with very little outsourcing. In terms of go-to-market, it uses warehouse distribution for big-box retailers, direct-store-delivery for convenience stores and other small outlets, and food-service distributors for the food-service channel (schools, hospitals, restaurants). It is controlled by chairman and CEO Nick Caporella, who owns over 73% of the common stock.
Read more on FIZZ →About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →
